CVS Health EBITDA 2010-2025 | CVS
CVS Health annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- CVS Health EBITDA for the quarter ending March 31, 2025 was $4.528B, a 32.82% increase year-over-year.
- CVS Health EBITDA for the twelve months ending March 31, 2025 was $14.232B, a 16.63% decline year-over-year.
- CVS Health 2024 annual EBITDA was $13.113B, a 27.59% decline from 2023.
- CVS Health 2023 annual EBITDA was $18.109B, a 48.7% increase from 2022.
- CVS Health 2022 annual EBITDA was $12.178B, a 33.19% decline from 2021.
| CVS Health Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $13,113 |
| 2023 | $18,109 |
| 2022 | $12,178 |
| 2021 | $18,227 |
| 2020 | $18,352 |
| 2019 | $16,358 |
| 2018 | $12,888 |
| 2017 | $12,198 |
| 2016 | $12,861 |
| 2015 | $11,567 |
| 2014 | $10,730 |
| 2013 | $9,907 |
| 2012 | $8,963 |
| 2011 | $7,899 |
| 2010 | $7,606 |
| 2009 | $7,814 |
| CVS Health Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $4,528 |
| 2024-12-31 | $3,515 |
| 2024-09-30 | $1,993 |
| 2024-06-30 | $4,196 |
| 2024-03-31 | $3,409 |
| 2023-12-31 | $4,507 |
| 2023-09-30 | $4,817 |
| 2023-06-30 | $4,338 |
| 2023-03-31 | $4,447 |
| 2022-12-31 | $4,702 |
| 2022-09-30 | $-2,869 |
| 2022-06-30 | $5,751 |
| 2022-03-31 | $4,594 |
| 2021-12-31 | $3,435 |
| 2021-09-30 | $4,626 |
| 2021-06-30 | $5,463 |
| 2021-03-31 | $4,703 |
| 2020-12-31 | $3,663 |
| 2020-09-30 | $4,363 |
| 2020-06-30 | $5,782 |
| 2020-03-31 | $4,544 |
| 2019-12-31 | $4,133 |
| 2019-09-30 | $4,020 |
| 2019-06-30 | $4,404 |
| 2019-03-31 | $3,801 |
| 2018-12-31 | $3,859 |
| 2018-09-30 | $3,194 |
| 2018-06-30 | $3,195 |
| 2018-03-31 | $2,640 |
| 2017-12-31 | $3,797 |
| 2017-09-30 | $3,114 |
| 2017-06-30 | $2,875 |
| 2017-03-31 | $2,412 |
| 2016-12-31 | $3,648 |
| 2016-09-30 | $3,435 |
| 2016-06-30 | $2,976 |
| 2016-03-31 | $2,802 |
| 2015-12-31 | $3,332 |
| 2015-09-30 | $2,863 |
| 2015-06-30 | $2,750 |
| 2015-03-31 | $2,622 |
| 2014-12-31 | $2,810 |
| 2014-09-30 | $2,723 |
| 2014-06-30 | $2,696 |
| 2014-03-31 | $2,501 |
| 2013-12-31 | $2,675 |
| 2013-09-30 | $2,615 |
| 2013-06-30 | $2,421 |
| 2013-03-31 | $2,196 |
| 2012-12-31 | $2,740 |
| 2012-09-30 | $2,257 |
| 2012-06-30 | $2,139 |
| 2012-03-31 | $1,827 |
| 2011-12-31 | $2,354 |
| 2011-09-30 | $1,991 |
| 2011-06-30 | $1,875 |
| 2011-03-31 | $1,679 |
| 2010-12-31 | $2,121 |
| 2010-09-30 | $1,848 |
| 2010-06-30 | $1,869 |
| 2010-03-31 | $1,768 |
| 2009-12-31 | $2,234 |
| 2009-09-30 | $1,867 |
| 2009-06-30 | $1,982 |
| 2009-03-31 | $1,731 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $86.198B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $144.179B | 27.04 |
| Elevance Health (ELV) | United States | $84.314B | 10.88 |
| Cencora (COR) | United States | $57.484B | 20.00 |
| DiDi Global (DIDIY) | China | $23.485B | 24.95 |
| Natera (NTRA) | United States | $22.963B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.509B | 17.45 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.205B | 0.00 |
| Solventum (SOLV) | United States | $12.912B | 13.67 |
| CochLear (CHEOY) | Australia | $12.870B | 0.00 |
| ICON (ICLR) | Ireland | $11.851B | 11.02 |
| Revvity (RVTY) | United States | $11.644B | 20.04 |
| Viatris (VTRS) | United States | $10.704B | 3.68 |
| Avantor (AVTR) | United States | $9.363B | 13.60 |
| HealthEquity (HQY) | United States | $9.068B | 39.72 |
| Medpace Holdings (MEDP) | United States | $8.818B | 23.42 |
| Sonic Healthcare (SKHHY) | Australia | $8.465B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.445B | 14.59 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.269B | 25.15 |
| BrightSpring Health Services (BTSG) | United States | $4.058B | 37.23 |
| Sotera Health (SHC) | United States | $3.225B | 18.32 |
| Surgery Partners (SGRY) | United States | $2.781B | 36.17 |
| Alignment Healthcare (ALHC) | United States | $2.722B | 0.00 |
| Concentras Parent (CON) | United States | $2.652B | 15.33 |
| Organon (OGN) | United States | $2.594B | 2.76 |
| GeneDx Holdings (WGS) | United States | $2.556B | 98.45 |
| PACS (PACS) | United States | $1.958B | 0.00 |
| Ardent Health (ARDT) | United States | $1.904B | 8.12 |
| Progyny (PGNY) | United States | $1.840B | 40.49 |
| Premier (PINC) | United States | $1.796B | 13.63 |
| GoodRx Holdings (GDRX) | United States | $1.761B | 35.21 |
| Teladoc Health (TDOC) | United States | $1.412B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.181B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.171B | 8.91 |
| CareDx (CDNA) | United States | $1.074B | 16.77 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.806B | 7.54 |
| Nutex Health (NUTX) | United States | $0.658B | 9.96 |
| LifeMD (LFMD) | United States | $0.615B | 0.00 |
| Embecta (EMBC) | United States | $0.542B | 3.65 |
| InnovAge Holding (INNV) | United States | $0.532B | 0.00 |
| Enhabit (EHAB) | United States | $0.482B | 39.62 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| SBC Medicals (SBC) | United States | $0.464B | 0.00 |
| Omada Health (OMDA) | $0.460B | 0.00 | |
| Sonida Senior Living (SNDA) | United States | $0.459B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.312B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.249B | 0.00 |
| Beauty Health (SKIN) | United States | $0.244B | 0.00 |
| So-Young (SY) | China | $0.209B | 0.00 |
| Oncology Institute (TOI) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.172B | 28.17 |
| Pheton Holdings (PTHL) | China | $0.115B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.096B | 0.00 |
| KindlyMD (NAKA) | United States | $0.089B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.075B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.051B | 0.00 |
| Biodesix (BDSX) | United States | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |